XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer (Q33442854)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer |
scientific article |
Statements
1 reference
XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer (English)
1 reference
Baoan Chen
1 reference
Jifeng Feng
1 reference
Xinchen Sun
1 reference
Ning Sun
1 reference
Shukui Qin
1 reference
Fan Li
1 reference
Hongyan Cheng
1 reference
Yuandong Cao
1 reference
Jun Ma
1 reference
Lu Cheng
1 reference
Zuhong Lu
1 reference
Jiazhong Ji
1 reference
Yingfeng Zhou
1 reference
1 May 2009
1 reference
1 reference
41
1 reference
429-435
1 reference
Identifiers
1 reference
1 reference